Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
- Posted on September 30, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
